Charles Schwab Investment Management Inc. Purchases 18,555 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Charles Schwab Investment Management Inc. boosted its position in Addus HomeCare Co. (NASDAQ:ADUS) by 8.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 227,209 shares of the company’s stock after purchasing an additional 18,555 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Addus HomeCare were worth $30,226,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. UMB Bank n.a. boosted its stake in Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after purchasing an additional 88 shares during the period. Quest Partners LLC bought a new stake in Addus HomeCare in the 2nd quarter valued at $31,000. Farther Finance Advisors LLC boosted its stake in Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after purchasing an additional 366 shares during the period. Innealta Capital LLC bought a new stake in Addus HomeCare in the 2nd quarter valued at $44,000. Finally, Sandia Investment Management LP bought a new stake in Addus HomeCare in the 2nd quarter valued at $58,000. 95.35% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of the company’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the transaction, the chief executive officer now owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This represents a 8.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares of the company’s stock, valued at approximately $429,165. The trade was a 12.93 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.60% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have weighed in on ADUS. StockNews.com cut Addus HomeCare from a “buy” rating to a “hold” rating in a report on Tuesday. KeyCorp began coverage on Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective for the company. Macquarie reaffirmed an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. Stephens lifted their price objective on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a report on Thursday, November 14th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Addus HomeCare currently has a consensus rating of “Moderate Buy” and an average target price of $131.63.

Addus HomeCare Stock Performance

Addus HomeCare stock opened at $123.60 on Thursday. Addus HomeCare Co. has a 52 week low of $85.94 and a 52 week high of $136.12. The stock has a fifty day moving average of $126.69 and a 200-day moving average of $123.92. The stock has a market capitalization of $2.24 billion, a P/E ratio of 28.28, a price-to-earnings-growth ratio of 2.15 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. During the same quarter in the prior year, the firm earned $1.03 EPS. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. On average, research analysts forecast that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.